Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1481-1488

  Song, Rong Feng ^a   Li, Xiao Jun ^a   Cheng, Xiao Liang ^a   Fu, Ai Rong ^a   Wang, Yan Hua ^a   Feng, Yan Jun ^a   Xiong, Yan ^a  

^a JIANGXI CANCER HOSPITAL   (China)

Author keywords

Anti proliferative effects; Gastroenteric cancer; Nanoparticles; Paclitaxel; Trimethyl chitosan

Indexed keywords

CHITOSAN DERIVATIVE; N,N,N TRIMETHYL CHITOSAN; NANOPARTICLE; PACLITAXEL; PACLITAXEL LOADED N,N,N TRIMETHYL CHITOSAN NANOPARTICLE; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CHITOSAN; N-TRIMETHYL CHITOSAN CHLORIDE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CACO 2 CELL LINE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; INTERNALIZATION; M PHASE CELL CYCLE CHECKPOINT; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; SURFACE CHARGE; TUMOR XENOGRAFT; ANIMAL; CELL CYCLE CHECKPOINT; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GASTROINTESTINAL NEOPLASMS; SMALL INTESTINE; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINE, SMALL; MICE; NANOPARTICLES; PACLITAXEL; POLYMERS; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84923068291     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3344     Document Type: Article

References (30)

1. Oh SC: Update of adjuvant chemotherapy for resected gastric cancer. J Gastric Cancer 12: 3-6, 2012.
2. Schwarz RE and Smith DD: Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol 14: 317-328, 2007. (Pubitemid 46175271)
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. Rowinsky EK, Cazenave LA and Donehower RC: Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1259, 1990. (Pubitemid 20239995)
5. Mancuso A, Oudard S and Sternberg CN: Effective chemotherapy for hormone-refractory prostate cancer (HRPC): present status and perspectives with taxane-based treatments. Crit Rev Oncol Hematol 61: 176-185, 2007. (Pubitemid 46091748)
6. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, et al: Hypersensitivity reactions from taxol. J Clin Oncol 8: 1263-1268, 1990. (Pubitemid 20195638)
7. Akhlaghi SP, Saremi S, Ostad SN, Dinarvand R and Atyabi F: Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. Nanomedicine 6: 689-697, 2010.
8. Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo J, Sha X and Fang X: Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. Eur J Pharm Biopharm 75: 341-353, 2010.
9. de Britto D and Assis OBG: A novel method for obtaining a quaternary salt of chitosan. Carbohydr Polym 69: 305-310, 2007. (Pubitemid 46629100)
10. Slütter B and Jiskoot W: Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination. J Control Release 148: 117-121, 2010.
11. Subbiah R, Ramalingam P, Ramasundaram S, et al: N,N,N-trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV surface antigen. Carbohydr Polym 89: 1289-1297, 2012.
12. Hamman JH, Stander M and Kotze AF: Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm 232: 235-242, 2002. (Pubitemid 34076769)
13. de Britto D, Forato LA and Assis OBG: Determination of the average degree of quaternization of N,N,N-trimethylchitosan by solid state C-13 NMR. Carbohydr Polym 74: 86-91, 2008.
14. de Moura MR, Aouada FA, Avena-Bustillos RJ, McHugh TH, Krochta JM and Mattoso LHC: Improved barrier and mechanical properties of novel hydroxypropyl methylcellulose edible films with chitosan/tripolyphosphate nanoparticles. J Food Eng 92: 448-453, 2009.
15. de Britto D, de Moura MR, Aouada FA, Mattoso LHC and Assis OBG: N,N,N-trimethyl chitosan nanoparticles as a vitamin carrier system. Food Hydrocoll 27: 487-493, 2012.
16. Bhumkar DR and Pokharkar VB: Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech 7: E50, 2006.
17. Chen F, Zhang ZR and Huang Y: Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers. Int J Pharm 336: 166-173, 2007. (Pubitemid 46551555)
18. Gan Q and Wang T: Chitosan nanoparticle as protein delivery carrier - systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 59: 24-34, 2007. (Pubitemid 47016920)
19. Qi L, Xu Z, Jiang X, Hu C and Zou X: Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 339: 2693-2700, 2004. (Pubitemid 39425140)
20. Davda J and Labhasetwar V: Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 233: 51-59, 2002. (Pubitemid 34230418)
21. Yu B, Zhang Y, Zheng W, Fan C and Chen T: Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles. Inorg Chem 51: 8956-8963, 2012.
22. Ganesh T, Yang C, Norris A, et al: Evaluation of the tubulin?bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3′ bridged paclitaxel analogues. J Med Chem 50: 713-725, 2007. (Pubitemid 46332984)
23. Sharma AK, Zhang L, Li S, Kelly DL, Alakhov VY, Batrakova EV and Kabanov AV: Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant. J Control Release 131: 220-227, 2008.
24. Guo DD, Moon HS, Arote R, Seo JH, Quan JS, Choi YJ and Cho CS: Enhanced anticancer effect of conjugated linoleic acid by conjugation with Pluronic F127 on MCF-7 breast cancer cells. Cancer Lett 254: 244-254, 2007. (Pubitemid 47126692)
25. Guo DD, Xu CX, Quan JS, Song CK, Jin H, Kim DD, Choi YJ, Cho MH and Cho CS: Synergistic anti-tumor activity of paclitaxel?incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo. Biomaterials 30: 4777-4785, 2009.
26. Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE: Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release 116: 150-158, 2006. (Pubitemid 44868999)
27. Ng SSW, Tsao MS, Chow S and Hedley DW: Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res 60: 5451-5455, 2000.
28. Kim K, Kim JH, Park H, Kim YS, Park K, Nam H, et al: Tumor?homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring. J Control Release 146: 219-227, 2010.
29. Zhang L, He Y, Ma G, Song C and Sun H: Paclitaxel-loaded polymeric micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε- caprolactone) triblock copolymers: in vitro and in vivo evaluation. Nanomedicine 8: 925-934, 2012.
30. Xiao K, Luo J, Fowler WL, Li Y, Lee JS, Xing L, Cheng RH, Wang L and Lam KS: A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials 30: 6006-6016, 2009.